The molecular acrobatics of arrestin activation

Trends in Pharmacological Sciences

Volumn 25, Issue 2, 2004, Pages 105-111

  Gurevich, Vsevolod V ^a   Gurevich, Eugenia V ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PHOSPHATE; RETINA S ANTIGEN;

BIOSENSOR; CONFORMATIONAL TRANSITION; DESENSITIZATION; DISSOCIATION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FAMILY; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY; REVIEW;

EID: 0842331059     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2003.12.008     Document Type: Review

References (57)

1. Perry S.J., Lefkowitz R.J. Arresting developments in heptahelical receptor signaling and regulation. Trends Cell Biol. 12:2002;130-138.
2. Hunzicker-Dunn M., et al. ARF6: a newly appreciated player in G protein-coupled receptor desensitization. FEBS Lett. 521:2002;3-8.
3. Perry S.J., et al. Targeting of cyclic AMP degradation to β2-adrenergic receptors by β-arrestins. Science. 298:2002;834-836.
4. Claing A., et al. beta-arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis. J. Biol. Chem. 276:2001;42509-42513.
5. Goodman O.B., et al. β-arrestin functions as a clathrin adaptor to promote β2-adrenergicreceptor endocytosis. Nature. 383:1996;447-450.
6. Laporte S.A., et al. The β2-adrenergic receptor/β-arrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc. Natl. Acad. Sci. U. S. A. 96:1999;3712-3717.
7. McDonald P.H., et al. Identification of NSF as a β-arrestin1- binding protein: implications for β2-adrenergic receptor regulation. J. Biol. Chem. 274:1999;10677-10680.
8. Luttrell L.M., et al. β-Arrestin-dependent formation of β2-adrenergic receptor-Src protein kinase complexes. Science. 283:1999;655-661.
9. Luttrell L.M., et al. Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds. Proc. Natl. Acad. Sci. U. S. A. 98:2001;2449-2454.
10. McDonald P.H., et al. β-Arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science. 290:2000;1574-1577.
11. Hirsch J.A., et al. The 2.8A crystal structure of visual arrestin: a model for arrestin's regulation. Cell. 97:1999;257-269.
12. Han M., et al. Crystal structure of β-arrestin at 1.9 Å: possible mechanism of receptor binding and membrane translocation. Structure. 9:2001;869-880.
13. Vishnivetskiy S.A., et al. Arrestin transition into the active receptor-binding state requires an extended interdomain hinge. J. Biol. Chem. 277:2002;43961-43967.
14. Vishnivetskiy S.A., et al. An additional phosphate-binding element in arrestin molecule: implications for the mechanism of arrestin activation. J. Biol. Chem. 275:2000;41049-41057.
15. Vishnivetsky S.A., et al. How does arrestin respond to the phosphorylated state of rhodopsin? J. Biol. Chem. 274:1999;11451-11454.
16. Gurevich V.V., Benovic J.L. Visual arrestin interaction with rhodopsin: Sequential multisite binding ensures strict selectivity towards light-activated phosphorylated rhodopsin. J. Biol. Chem. 268:1993;11628-11638.
17. Angers S., et al. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42:2002;409-435.
18. Palczewski K., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science. 289:2000;739-745.
19. Granzin J., et al. X-ray crystal structure of arrestin from bovine rod outer segments. Nature. 391:1998;918-921.
20. Milano S.K., et al. Scaffolding functions of arrestin-2 revealed by crystal structure and mutagenesis. Biochemistry. 41:2002;3321-3328.
21. Lambright D.G., et al. The 2.0 A crystal structure of a heterotrimeric G protein. Nature. 379:1996;311-319.
22. Celver J., et al. Conservation of the phosphate-sensitive elements in the arrestin family of proteins. J. Biol. Chem. 277:2002;9043-9048.
23. Kovoor A., et al. Targeted construction of phosphorylation-independent β-arrestin mutants with constitutive activity in cells. J. Biol. Chem. 274:1999;6831-6834.
24. Gurevich V.V., et al. Arrestin interactions with G protein-coupled receptors: direct binding studies with rhodopsin, β2-adrenergic, and m2 muscarinic cholinergic receptors. J. Biol. Chem. 270:1995;720-731.
25. Gurevich V.V., et al. Agonist-receptor-arrestin, an alternative ternary complex with high agonist affinity. J. Biol. Chem. 272:1997;28849-28852.
26. Palczewski K., et al. Regulation of rhodopsin dephosphorylation by arrestin. J. Biol. Chem. 264:1989;15770-15773.
27. Gurevich V.V., Benovic J.L. Visual arrestin binding to rhodopsin: diverse functional roles of positively charged residues within the phosphorylation-recognition region of arrestin. J. Biol. Chem. 270:1995;6010-6016.
28. Gurevich V.V. The selectivity of visual arrestin for light-activated phosphorhodopsin is controlled by multiple non-redundant mechanisms. J. Biol. Chem. 273:1998;15501-15506.
29. Gurevich V.V., Benovic J.L. Cell-free expression of visual arrestin: truncation mutagenesis identifies multiple domains involved in rhodopsin interaction. J. Biol. Chem. 267:1992;21919-21923.
30. Smith W.C., et al. Cloning and functional characterization of salamander rod and cone arrestins. Invest. Ophthalmol. Vis. Sci. 41:2000;2445-2455.
31. Smith W.C., et al. A splice variant of arrestin: molecular cloning and localization in bovine retina. J. Biol. Chem. 269:1994;15407-15410.
32. Gurevich V.V., Benovic J.L. Mechanism of phosphorylation-recognition by visual arrestin and its role in arrestin transition into high-affinity binding state. Mol. Pharmacol. 51:1997;161-169.
33. Kennedy M.J., et al. Multiple phosphorylation of rhodopsin and the in vivo chemistry underlying rod photoreceptor dark adaptation. Neuron. 31:2001;87-101.
34. Brannock M.T., et al. Rhodopsin's carboxyl-terminal threonines are required for wild-type arrestin-mediated quench of transducin activation in vitro. Biochemistry. 38:1999;3770-3777.
35. Mendez A., et al. Rapid and reproducible deactivation of rhodopsin requires multiple phosphorylation sites. Neuron. 28:2000;153-164.
36. Schleicher A., et al. Kinetics, binding constant, and activation energy of the 48-kDA protein-rhodopsin complex by extra-Metarhodopsin II. Biochemistry. 28:1989;1770-1775.
37. Shilton B.H., et al. The solution structure and activation of visual arrestin studied by small-angle X-ray scattering. Eur. J. Biochem. 269:2002;3801-3809.
38. Pulvermuller A., et al. Functional differences in the interaction of arrestin and its splice variant, p44, with rhodopsin. Biochemistry. 36:1997;9253-9260.
39. Vishnivetskiy, S.A. et al. Mapping arrestin-receptor interface: structural elements responsible for receptor specificity of arrestins. J. Biol. Chem. (in press).
40. Palczewski K., et al. Phosphorylated rhodopsin and heparin induce similar conformational changes in arrestin. J. Biol. Chem. 266:1991;18649-18654.
41. Gurevich V.V., Gurevich E.V. The new face of active receptor-bound arrestin attracts new partners. Structure. 11:2003;1037-1042.
42. Lin F.-T., et al. Phosphorylation of β-arrestin2 regulates its function in internalization of β2-adrenergic receptors. Biochemistry. 41:2002;10692-10699.
43. Lin F.-T., et al. Feedback regulation of b-arrestin1 function by extracellular signal-regulated kinases. J. Biol. Chem. 274:1999;15971-15974.
44. McDowell J.H., et al. Sulfhydryl reactivity demonstrates different conformational states for arrestin, arrestin activated by a synthetic phosphopeptide, and constitutively active arrestin. Biochemistry. 38:1999;6119-6125.
45. Oakley R.H., et al. Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J. Biol. Chem. 274:1999;32248-32257.
46. Oakley R.H., et al. Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J. Biol. Chem. 275:2000;17201-17210.
47. Oakley R.H., et al. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis. J. Biol. Chem. 276:2001;19452-19460.
48. Lin F.T., et al. beta-Arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor. J. Biol. Chem. 273:1998;31640-31643.
49. Chen W., et al. Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Science. 301:2003;1394-1397.
50. Spiegel A. Beta-arrestin-not just for G protein-coupled receptors. Science. 301:2003;1338-1339.
51. Wu J.-H., et al. The adaptor protein β-arrestin2 enhances endocytosis of the low density lipoprotein receptor. J. Biol. Chem. 278:2003;44238-44245.
52. Kobilka B.K. Agonist-induced conformational changes in the beta2 adrenergic receptor. J. Pept. Res. 60:2002;317-321.
53. Key T.A., et al. N-formyl peptide receptor phosphorylation domains differentially regulate arrestin and agonist affinity. J. Biol. Chem. 278:2003;4041-4047.
54. Vines C.M., et al. N-formyl peptide receptors internalize but do not recycle in the absence of arrestins. J. Biol. Chem. 278:2003;41581-41584.
55. Pan L., et al. The nature of the arrestin-receptor complex determines the ultimate fate of the internalized receptor. J. Biol. Chem. 278:2003;11623-11632.
56. Shenoy S.K., Lefkowitz R.J. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination. J. Biol. Chem. 278:2003;14498-14506.
57. Shenoy S.K., et al. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science. 294:2001;1307-1313.